Competition in the Internet-based medical C-end market has become increasingly fierce, and investment institutions have begun to pay attention to the B-end market, which is not yet fully competitive. Among them, To B's pharmaceutical e-commerce unicorn, Pharmacist Gang, has received the most attention.

In June 2021, Pharmacist Gang announced the completion of a new round of financing of US$270 million. Zhujiang Investment, Baidu, Sunshine Insurance, Songhe Capital, Guangzhou Fund and a national sovereign fund participated in this round of financing. According to a reporter from Times Weekly, this round of financing will be mainly used for technical upgrades in all aspects of contract performance, the iteration and construction of digital marketing systems for pharmaceutical companies outside the hospital, and the construction of data sharing platforms for professional service scenarios in pharmacies and clinics.